LAUREN NICOLOSI: Open Payments
NPI 1093332991 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 35 payments from 7 companies in 2025. Trend: 2023 $235 · 2024 $977 · 2025 $1,601
Food & beverage: $1,601
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 20 | $1,125 |
| Ipsen Biopharmaceuticals, Inc | 5 | $163 |
| AstraZeneca Pharmaceuticals LP | 2 | $136 |
| Gilead Sciences, Inc. | 4 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| ABBVIE INC. | 1 | $23 |
| Mirum Pharmaceuticals, Inc. | 1 | $18 |
Products named: REZDIFFRA, IQIRVO, XIFAXAN, MAVYRET, Livmarli, LOKELMA.
Industry payments across NY — which companies pay providers there.
